Chardonnet Laurent 4
4 · Prelude Therapeutics Inc · Filed Dec 1, 2021
Insider Transaction Report
Form 4
Chardonnet Laurent
Chief Financial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2021-11-29+180,000→ 180,000 totalExercise: $13.75Exp: 2031-11-28→ Common Stock (180,000 underlying)
Footnotes (1)
- [F1]The stock option vests as to 25% of the total shares on November 29, 2022, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.